We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUID icon
4526
authID Inc
AUID
$7.91M
$7K ﹤0.01%
1,528
+1,383
+954% +$13K
BATRK icon
4527
Atlanta Braves Holdings Series B
BATRK
$3.41B
$7K ﹤0.01%
215
-2,605
-92% -$81.2K
BBGI icon
4528
Beasley Broadcasting Group
BBGI
$39.3M
$7K ﹤0.01%
363
+53
+17% +$1.08K
BKE icon
4529
Buckle
BKE
$2.33B
$7K ﹤0.01%
151
-11,257
-99% -$455K
BRKL
4530
DELISTED
Brookline Bancorp
BRKL
$7K ﹤0.01%
478
-8,822
-95% -$118K
BRZU icon
4531
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.2M
$7K ﹤0.01%
+96
New +$7.38K
BSY icon
4532
Bentley Systems
BSY
$10.8B
$7K ﹤0.01%
182
-4,257
-96% -$154K
BTCS icon
4533
BTCS Inc
BTCS
$54.3M
$7K ﹤0.01%
11,430
+4,770
+72% +$5.21K
CAKE icon
4534
Cheesecake Factory
CAKE
$5.84B
$7K ﹤0.01%
224
-4,941
-96% -$165K
CARS icon
4535
Cars.com
CARS
$648M
$7K ﹤0.01%
489
-4,363
-90% -$59.1K
CASI
4536
DELISTED
CASI Pharmaceuticals
CASI
$7K ﹤0.01%
3,494
+1,189
+52% +$2.36K
BNC
4537
CEA Industries
BNC
$104M
$7K ﹤0.01%
652
+48
+8% +$561
CHCI icon
4538
Comstock Holding Companies
CHCI
$152M
$7K ﹤0.01%
1,627
+233
+17% +$969
CLDT
4539
Chatham Lodging
CLDT
$590M
$7K ﹤0.01%
586
-2,767
-83% -$34.1K
CLMT icon
4540
Calumet Specialty Products
CLMT
$4.15B
$7K ﹤0.01%
388
-2,174
-85% -$35.1K
CMTL icon
4541
Comtech Telecommunications
CMTL
$52.1M
$7K ﹤0.01%
569
-1,190
-68% -$13.4K
CODX
4542
Co-Diagnostics
CODX
$5.49M
$7K ﹤0.01%
96
-866
-90% -$81.1K
COLL icon
4543
Collegium Pharmaceutical
COLL
$913M
$7K ﹤0.01%
301
-1,497
-83% -$30.2K
CPHC icon
4544
Canterbury Park Holding Corp
CPHC
$80.8M
$7K ﹤0.01%
226
-398
-64% -$10.2K
CRVL icon
4545
CorVel
CRVL
$3.25B
$7K ﹤0.01%
156
-1,929
-93% -$96K
DCOM icon
4546
Dime Commercial Bancshares
DCOM
$1.81B
$7K ﹤0.01%
233
-4,864
-95% -$160K
DFE icon
4547
WisdomTree Europe SmallCap Dividend Fund
DFE
$169M
$7K ﹤0.01%
134
DGII icon
4548
Digi International
DGII
$3.23B
$7K ﹤0.01%
189
-1,459
-89% -$56.2K
DJCO icon
4549
Daily Journal
DJCO
$828M
$7K ﹤0.01%
28
-68
-71% -$18.4K
DNOW icon
4550
DNOW Inc
DNOW
$3.04B
$7K ﹤0.01%
586
-13,803
-96% -$167K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.